| 摘要 |
PURPOSE: A pharmaceutical composition containing matairesinol for suppressing angiogenesis is provided to effectively prevent or treat angiogenesis-related diseases or disorders. CONSTITUTION: A pharmaceutical composition for suppressing angiogenesis contains a compound of chemical formula 1 as an active ingredient. The compound of chemical formula 1 is a compound of chemical formula 2. The pharmaceutical composition is used for preventing or treating uncontrolled angiogenesis-related diseases or disorders such as cancer, diabetic retinopathy, retinopathy of prematurity, corneal graft rejection, neovascular glaucoma, erythrosis, proliferative retinopathy, psoriasis, hemophilic joint, capillary increase in atherosclerotic plaques, keloid, wound granulation, vascular adhesion, rheumatoid arthritis, osteoarthritis, autoimmune disease, Crohn's disease, recurrent stricture, atherosclerosis, intestinal tract adhesion, cat scratch disease, ulcer, cirrhosis, glomerulonephritis, diabetic nephropathy, malignant nephrosclerosis, thrombotic microangiopathy, organ graft rejection, glomerulopathy, diabetes, inflammation, or neurodegenerative disease. |
